SOPHiA GENETICS SA - Ordinary Shares (SOPH)

SOPHiA GENETICS Q3 2025 results beat revenue estimates and the company raised its full-year 2025 outlook, driving positive investor sentiment.

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings.

San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic move marks a significant pivot for the genomic sequencing giant, as it ventures deeper into the burgeoning fields

SOPHiA GENETICS beats Q2 2025 estimates with $18.32M revenue and $0.33 EPS, driving shares up 5.45% in pre-market trading.

SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

CoreWeave, a company backed by Nvidia, is preparing to go public in 2025.

SOPH stock results show that Sophia Genetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Shares of CrowdStrike Holdings, Inc. (NASDAQ: CRWD) shares surged 24.4% to $370.27 in pre-market trading after the company reported better-than-expected fourth-quarter earnings and revenues and issued upbeat guidance for FY25.

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

We're starting Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!

U.S. stock futures were higher this morning, with the Nasdaq futures gaining by around 100 points on Wednesday.

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.